Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue 5, 2006, Pages 493-497

  Oliveira, Ana Carla Pozzi ^a   Shinobu, Cristiane Suemi ^a   Longhini, Renata ^a   Franco, Selma Lucy ^a   Svidzinski, Terezinha Inez Estivalet ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antifungal activity; Flavonoids; Onychomycosis; Propolis; Yeasts

Indexed keywords

CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; FUNGI; TRICHOSPORON (UNCLASSIFIED);

EID: 33747848295     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762006000500002     Document Type: Article

References (31)

1. Araújo AJG, Bastos OMP, Souza MAJ, Oliveira JC 2003. Onychomycosis caused by emergent fungi: clinical analysis, diagnosis and revision. An Bras Dermatol 78: 445-455.
2. Baran R, Kaoukhov A 2005. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol 19: 21-29.
3. Baran R, Gupta AK, Pierard GE 2005 Pharmacotherapy of onychomycosis. Expert Opin Pharmacother 6: 609-624.
4. Brilhante RSN, Cordeiro RA, Medrano DJA, Rocha MFG, Monteiro AJ, Cavalcante CSP, Meireles, TEF, Sidrim JJC 2005. Onychomycosis in Ceará (Northeast Brazil): epidemiological and laboratory aspects. Mem Inst Oswaldo Cruz 100: 131-135.
5. Burdock GA 1998. Review of the biological properties and toxicity of bee propolis. Food Chem Toxicol: 347-363.
6. Calvo MCR, Tomás JG, Ruesca RB 1996. Valoración in vitro de la sensibilidad a los antifúngicos. Rev Iberoam Micol 13: 60-63.
7. Castaldo S, Capasso F 2002. Propolis, an old remedy used in modern medicine Fitoterapia 73: s1-s6.
8. Chi CC, Wang SH, Chou MC 2005. The causative pathogens of onychomycosis in southern Taiwan. Mycoses 48: 413-420.
9. Cushnie TPT, Lamb AJ 2005. Antimicrobial activity of flavonoids. Int J Antimicrobial Agents 26:343-356.
10. De Castro SL 2001. Propolis: biological and pharmacological activities. Arbs Amn Rev Biomed Sci 3: 49-83.
11. Dorko E, Jautova J, Tkacikova L, Wantrubova A 2002. The frequency of Candida species in onychomycosis. Folia Microbiol 47: 727-731.
12. Effendy I, Lecha M, Feuilhade de Chauvin M, Di Chiacchio N, Baran R 2005. European Onychomycosis Observatory. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol 19: 8-12.
13. Ellabib MS, Agaj M, Khalifa Z, Kavanagh K 2002. Yeasts of the genus Candida are the dominant cause of onychomycosis in Libyan women but not men: results of a 2-year surveillance study. Br J Dermatol 146: 1038-1041.
14. Farmacopéia Brasileira 1988. 4. ed., Atheneu, São Paulo, p. 1.3.1.
15. Fouilloux B 2003. Onychomycosis and quality of life. Ann Dermatol Venereol 130: 1275-1278.
16. Franco SL, Bueno JHF 1999. Otimização de processo extrativo de própolis. Infarma 11: 48-51.
17. Garg A, Venkatesh V, Singh M, Pathak KP, Kaushal GP, Agrawal SK 2004. Onychomycosis in central India: a clinicoetiologic correlation. Int J Dermatol 43: 498-502.
18. Gupta AK, Ryder JE, Johnson AM 2004a. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol 150: 537-544.
19. Gupta AK, Ryder JE, Summerbell RC 2004b. Onychomycosis: classification and diagnosis. J Drugs Dermatol 3: 51-56.
20. Ilkit M 2005. Onychomycosis in Adana, Turkey: a 5-year study. Int J Dermatol 44: 851-854.
21. Ioannidou DJ, Maraki S, Krasagakis SK, Tosca A, Tselentis Y 2006. The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001. J Eur Acad Dermatol Venereol 20: 170-174.
22. Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R 2005. Taskforce on Onychomycosis Education. Treatment options-development of consensus guidelines. J Eur Acad Dermatol Venereol 19: 25-33.
23. Madrenys-Brunet N, Torres-Rodrígue JM, Urea-Arbeláez A 1996. Estudo epidemiológico de las micosis ungueales en Barcelona. Rev Iberoam Micol 13: 14-17.
24. Mello JCP, Petereit F and Nahrstedt A 1996. Prorobinetinidins from Sthryphnodendron adstringens. Phytochemistry 42: 857-862.
25. Mujica MT, Finquelievich JL, Jewtuchowicz V, Iovannitti CA 2004. Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001. Rev Argent Microbiol 36: 107-112.
26. NCCLS-National Committee for Clinical Laboratory Standards 1997. Reference method for broth dilution antifungal susceptibility testing for yeasts. Approved standard M27-A, Wayne, PA.
27. Roberts DT, Taylor WD, Boyle J 2003. Guidelines for treatment of onychomycosis. Br J Dermatol 148: 402-410.
28. Romano C, Gianni C, Difonzo EM 2005. Retrospective study of onychomycosis in Italy: 1985-2000. Mycoses 48: 42-44.
29. Sommez S, Kirilmaz L, Yucesoy M, Yücel B, Ylmaz B 2005. The effect of bee propolis on oral pathogens and human gingival fibroblast. J Ethnopharmacol 102:371-376
30. Summerbell RC, Cooper E, Bunn U, Jamieson F, Gupta Ak 2005. Onychomycosis: a critical study of techniques and criteria for confirming the etiologic significance of nondermatophytes. Med Mycol 43: 39-59.
31. Torres-Rodrígues JM 1996. Nuevos hongos patogenos oportunistas emergentes. Rev Iberoam Micol 13: 30-33.